preparation of factor vii concentrate using cnbr-activated

background: factor vii concentrates are used in patients with congenital or acquired factor vii deficiency or treatment of hemophilia patients with inhibitors. in this research, immunoaffinity chromatography was used to purify factor vii from prothrombin complex (prothrombin-proconvertin-stuart factor-antihemophilic factor b or ppsb) which contains coagulation factors ii, vii, ix and x. the aim of this study was to improve purity, safety and tolerability as a highly purified factor vii concentrate.   methods : ppsb was prepared using deae-sephadex and was used as the starting material for purification of coagulation factor vii. prothrombin complex was treated by solvent/detergent at 24°c for 6 h with constant stirring. the mixture of ppsb in the pbs buffer was filtered and then chromatographed using cnbr-activated sepharose 4b coupled with specific antibody. factors ii, ix, vii, x and viia were assayed on the fractions. fractions of 48-50 were pooled and lyophilized as a factor vii concentrate. agarose gel electrophoresis was performed and tween 80 was measured in the factor vii concentrate.   results : specific activity of factor vii concentrate increased from 0.16 to 55.6 with a purification-fold of 347.5 and the amount of activated factor vii (fviia) was found higher than ppsb (4.4-fold). results of electrophoresis on agarose gel indicated higher purity of factor vii compared to ppsb these finding revealed that factor vii migrated as alpha-2 proteins. in order to improve viral safety, solvent-detergent treatment was applied prior to further purification and nearly complete elimination of tween 80 (2 μg/ml).   conclusion : it was concluded that immuonoaffinity chromatography using cnbr-activated sepharose 4b can be a suitable choice for large-scale production of factor vii concentrate with higher purity, safety and activated factor vii.